DoW Toxic Exposures Clinical Trial Award
Award amountNot stated
Grants for businesses: prevention
The intersection of two stored fields: the eligible-applicant field includes business, including records the funder marked open to any applicant, and the stated use of funds is prevention.
Records linked7In this slice
Median award ceiling$350,000Computed from 1 of 7 records with a stated ceiling
Award ceiling range$350,000 – $350,000Lowest stated floor to highest stated ceiling
Program pools (total)$151,900,000Sum of programme totals across 4 records. Not an amount any applicant receives.
Next linked deadlines
DoW Toxic Exposures Clinical Trial AwardNov 19, 2026
7 of 7 records carry a stated deadline; 0 are rolling and the rest read Not stated.
Funder type distribution
Federal7
Counted from linked records only.
Displaying 1 – 7 of 7
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Award ceilingup to $350,000
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Award amountNot stated
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
Award amountNot stated
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
Award amountNot stated
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
Award amountNot stated
Other applicant types
Related industries
Other funding levels
Applicant type in a state
Elsewhere in the library